apologize for giving the wrong Rojkind reference. For historical interest, we used the 1976 (3) publication, but by error, referred to the 1979 one ( 1). Dr. W. J. Lindblad makes an excellent point. The methods section was markedly abbreviated and the paper, as published, does give the misleading i
Exudative Ascites in the Course of Acute Type B Hepatitis
✍ Scribed by Carmen Viola; Lydia Vineta; Jaime Bosch; Juan Rodés
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 300 KB
- Volume
- 3
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
✦ Synopsis
Two patients who presented with an exudative ascites in the course of typical acute type B hepatitis are reported. In one of them, ascites was associated with an exudative pleural effusion. In both patients, the clinical course of the hepatitis was uneventful, and ascites and pleural effusion disappeared spontaneously. Portal hypertension and common causes of exudative ascites were excluded. It is suggested that the development of exudative ascites in these patients represent a hitherto unrecognized manifestation of the hepatitis itself.
📜 SIMILAR VOLUMES
Hepatitis B virus with a G-to-A point mutation at nucleotide 83 in the precore region (mutant hepatitis B virus 83), which cannot produce HBeAg, is commonly found in HBe antibody-positive hepatitis B virus carriers. We analyzed the consecutive changes in the prevalence of mutant hepatitis B virus 83
The prevalence and prognostic significance of spontaneous bacterial peritonitis were prospectively studied in a series of 82 acute hepatitis patients decompensated with ascites. The in-hospital prevalence of spontaneous bacterial peritonitis was 31.7% (26 of 82 patients). Twenty cases were culture p
## Abstract Hepatitis B virus (HBV), with a G‐to‐A point mutation at nucleotide 83 in the precore region (mutant HBV83), accounts for most cases of hepatitis B e antigen (HBeAg)‐defective HBV. However, it is still not clear how mutant HBV83 is associated with HBe seroconversion. Twenty‐six HBeAgpos
Hepatitis C virus RNA, anti-hepatitis C virus immune response and biochemical markers of liver injury were investigated in 17 patients with acute non-A, non-B hepatitis. At the first observation, 1 to 3 wk from the clinical onset, all patients had hepatitis C virus RNA in their serum, and most (15 o
The human MxA protein is a new specific marker for type I interferon activity both in uitro and in uiuo. In the study presented here this interferon-induced marker, as well as the 2',S'-oligoadenylate synthetases, was measured in circulating mononuclear cells from 2 1 patients with acute hepatitis A